|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1994-5-12
|
|
pubmed:abstractText |
This study was undertaken to evaluate the feasibility and therapeutic effect of high-dose chemoradiotherapy with autologous or allogeneic bone marrow transplantation (BMT) in patients with advanced chronic lymphocytic leukemia (CLL) who relapse after fludarabine treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
748-58
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8151318-Adult,
pubmed-meshheading:8151318-Aged,
pubmed-meshheading:8151318-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8151318-Bone Marrow Transplantation,
pubmed-meshheading:8151318-Combined Modality Therapy,
pubmed-meshheading:8151318-Feasibility Studies,
pubmed-meshheading:8151318-Female,
pubmed-meshheading:8151318-Humans,
pubmed-meshheading:8151318-Immunomagnetic Separation,
pubmed-meshheading:8151318-Immunophenotyping,
pubmed-meshheading:8151318-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:8151318-Male,
pubmed-meshheading:8151318-Middle Aged,
pubmed-meshheading:8151318-Recurrence,
pubmed-meshheading:8151318-Treatment Outcome
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results.
|
|
pubmed:affiliation |
Division of Medicine, University of Texas M.D. Anderson Cancer Center, Houston.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
